9. |
ACCRUED
EXPENSES AND LONG-TERM LIABILITIES |
Other
accrued expenses consisted of the following as of March 31, 2022 and December 31, 2021:
SCHEDULE OF OTHER ACCRUED EXPENSES
|
|
March
31, 2022 |
|
|
December
31, 2021 |
|
|
|
(unaudited) |
|
|
|
|
Accrued
royalties |
|
$ |
4,116 |
|
|
$ |
3,890 |
|
Contingent
consideration |
|
|
488 |
|
|
|
488 |
|
Operating
lease liability |
|
|
999 |
|
|
|
1,041 |
|
Financing
lease liability |
|
|
70 |
|
|
|
79 |
|
Deferred
revenue |
|
|
31 |
|
|
|
40 |
|
Interest
payable |
|
|
62 |
|
|
|
120 |
|
Warrant
liability |
|
|
8 |
|
|
|
71 |
|
Accrued
sales and marketing - diagnostics |
|
|
63 |
|
|
|
47 |
|
Accrued
lab costs - diagnostics |
|
|
185 |
|
|
|
228 |
|
Accrued
professional fees |
|
|
707 |
|
|
|
932 |
|
Taxes
payable |
|
|
269 |
|
|
|
245 |
|
Unclaimed
property |
|
|
565 |
|
|
|
565 |
|
All
others |
|
|
1,129 |
|
|
|
1,452 |
|
Total
other accrued expenses |
|
$ |
8,692 |
|
|
$ |
9,198 |
|
Long-term
liabilities consisted of the following as of March 31, 2022 and December 31, 2021:
SCHEDULE OF LONG TERM LIABILITIES
|
|
March
31, 2022 |
|
|
December
31, 2021 |
|
|
|
(unaudited) |
|
|
|
|
Uncertain
tax positions |
|
$ |
4,631 |
|
|
$ |
4,577 |
|
Deferred
revenue |
|
|
13 |
|
|
|
13 |
|
Other |
|
|
41 |
|
|
|
58 |
|
Total
other long-term liabilities |
|
$ |
4,685 |
|
|
$ |
4,648 |
|
|